TEST:

AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer

AnchorAIM® 10 gene detection for individualized treatment of lung cancer, for lung cancer patients, applies high-throughput sequencing technology to accurately detect gene mutations most relevant to the efficacy of targeted lung cancer drugs, and provides the most clinically referenced genes for targeted tumor therapy information. Its suggests that the patient may be sensitive to icotinib, afatinib , gefitinib and erlotinib, and doctors can formulate corresponding treatment plans based on the patient's clinical information.